Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000120937 | SCV000302488 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV001094408 | SCV000399830 | benign | Fanconi anemia complementation group A | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Labcorp Genetics |
RCV000351747 | SCV000558864 | benign | Fanconi anemia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000120937 | SCV000603544 | benign | not specified | 2016-10-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705888 | SCV001900776 | benign | not provided | 2019-03-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31586946, 28864460, 10094191, 27153395, 27884173, 24728327, 20981092, 22995991) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000120937 | SCV002051221 | benign | not specified | 2021-12-18 | criteria provided, single submitter | clinical testing | Variant summary: FANCA c.3263C>T (p.Ser1088Phe) results in a non-conservative amino acid change in the encoded protein sequence. Two of three in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.051 in 250776 control chromosomes in the gnomAD database, including 459 homozygotes. The observed variant frequency is approximately 23.34 fold of the estimated maximal expected allele frequency for a pathogenic variant in FANCA causing Fanconi Anemia phenotype (0.0022), strongly suggesting that the variant is benign. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments. Based on the evidence outlined above, the variant was classified as benign. |
Sema4, |
RCV000351747 | SCV002534994 | benign | Fanconi anemia | 2020-02-06 | criteria provided, single submitter | curation | |
Breakthrough Genomics, |
RCV001705888 | SCV005253318 | benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000120937 | SCV000085105 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Caryl and Israel Englander Institute for Precision Medicine, |
RCV000488415 | SCV000494044 | uncertain significance | Malignant tumor of prostate | 2015-07-01 | flagged submission | research | |
Leiden Open Variation Database | RCV001094408 | SCV001426104 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | flagged submission | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. |
Natera, |
RCV001094408 | SCV001458821 | benign | Fanconi anemia complementation group A | 2019-08-23 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000120937 | SCV001927758 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000120937 | SCV001963397 | benign | not specified | no assertion criteria provided | clinical testing |